These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 18946343

  • 1. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L, Thiébaut R, Carron JC, Moreau JF, Merville P, Taupin JL.
    Transplantation; 2008 Oct 27; 86(8):1060-7. PubMed ID: 18946343
    [Abstract] [Full Text] [Related]

  • 2. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar 27; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 3. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.
    Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR.
    Transpl Int; 2010 May 01; 23(5):506-13. PubMed ID: 19951371
    [Abstract] [Full Text] [Related]

  • 4. Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients.
    Sadeghi M, Daniel V, Naujokat C, Schnitzler P, Schmidt J, Mehrabi A, Zeier M, Opelz G.
    Transplantation; 2008 Jul 27; 86(2):275-85. PubMed ID: 18645491
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M, Romano-Moreno S, García-Hernández M, Chevaile-Ramos JA, Layseca-Espinosa E, González-Amaro R, Portales-Pérez D.
    Transpl Immunol; 2009 May 27; 21(1):43-9. PubMed ID: 19233271
    [Abstract] [Full Text] [Related]

  • 6. Low levels of Th1-type cytokines and increased levels of Th2-type cytokines in kidney transplant recipients with active cytomegalovirus infection.
    Essa S, Pacsa A, Raghupathy R, Said T, Nampoory MR, Johny KV, Al-Nakib W.
    Transplant Proc; 2009 Jun 27; 41(5):1643-7. PubMed ID: 19545699
    [Abstract] [Full Text] [Related]

  • 7. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K, Tsukaguchi M, Toyama A, Satoh H, Saito K, Nakagawa Y, Takahashi K, Tanaka S, Onda K, Hirano T.
    Exp Clin Transplant; 2014 Jun 27; 12(3):195-9. PubMed ID: 24907718
    [Abstract] [Full Text] [Related]

  • 8. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G.
    Haematologica; 2008 Feb 27; 93(2):248-56. PubMed ID: 18245650
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D, Cesaro S, Cofano S, Fiscon M, Saldan A, Varotto S, Mengoli C, Pillon M, Calore E, Biasolo MA, Cusinato R, Barzon L, Messina C, Carli M, Palù G.
    Transplantation; 2012 Mar 15; 93(5):536-42. PubMed ID: 22314338
    [Abstract] [Full Text] [Related]

  • 10. The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients.
    Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS.
    J Infect Dis; 2000 Jan 15; 181(1):51-7. PubMed ID: 10608750
    [Abstract] [Full Text] [Related]

  • 11. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
    Sund F, Lidehäll AK, Claesson K, Foss A, Tötterman TH, Korsgren O, Eriksson BM.
    Clin Transplant; 2010 Jan 15; 24(3):401-9. PubMed ID: 19222507
    [Abstract] [Full Text] [Related]

  • 12. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE, Rentenaar RJ, van Lier RA, ten Berge IJ.
    Hum Immunol; 2004 May 15; 65(5):486-92. PubMed ID: 15172448
    [Abstract] [Full Text] [Related]

  • 13. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.
    Mikrobiyol Bul; 2016 Apr 15; 50(2):224-35. PubMed ID: 27175495
    [Abstract] [Full Text] [Related]

  • 14. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L.
    Transpl Immunol; 2009 Jan 15; 20(3):139-42. PubMed ID: 18834941
    [Abstract] [Full Text] [Related]

  • 15. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection.
    Essa S, Raghupathy R, Pacsa AS, El-Shazly A, Said T, Azizieh F.
    J Med Virol; 2000 Feb 15; 60(2):223-9. PubMed ID: 10596025
    [Abstract] [Full Text] [Related]

  • 16. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
    Yang R, Xia T, Xu G, Li Z, Ying Z, Xu X.
    Transplant Proc; 2008 Dec 15; 40(10):3500-4. PubMed ID: 19100424
    [Abstract] [Full Text] [Related]

  • 17. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Dec 15; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 18. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A, Lochman I, Tomaskova H, Marsalkova P, Raszka J, Mrazek J, Dedochova J, Martinek A, Brozmanova H, Grundmann M.
    Transplant Proc; 2010 Nov 15; 42(9):3574-7. PubMed ID: 21094818
    [Abstract] [Full Text] [Related]

  • 19. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 20. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.
    Godard B, Gazagne A, Gey A, Baptiste M, Vingert B, Pegaz-Fiornet B, Strompf L, Fridman WH, Glotz D, Tartour E.
    Hum Immunol; 2004 Nov 27; 65(11):1307-18. PubMed ID: 15556681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.